Carregant...
Planes, Trains and Automobiles: Perspectives on CAR T cells and other cellular therapies for hematologic malignancies
Hematologic oncologists now have at their disposal (or a referral away) a myriad of new options to get from point A (a patient with relapsed or poor-risk disease) to point B (potential tumor eradication and long-term disease-free survival). In this perspective piece we discuss the putative mechanism...
Guardat en:
| Publicat a: | Curr Hematol Malig Rep |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5018307/ https://ncbi.nlm.nih.gov/pubmed/27136938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-016-0330-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|